|
|
|
|
|
|
|
|
|
|
|
|
|
09.03.26 - 13:46
|
Actuate Therapeutics Launches Strategic Research Initiative to Combine Elraglusib with RAS Inhibitors (GlobeNewswire EN)
|
|
|
CHICAGO and FORT WORTH, Texas, March 09, 2026 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment of high-impact, difficult-to-treat cancers through the inhibition of glycogen synthase kinase-3 beta (GSK-3β), today announced the launch of an expanded research initiative evaluating combinations of its clinical-stage GSK-3β inhibitor elraglusib with emerging RAS-targeted therapies....
|
|
|
|
|
|
|
09.03.26 - 13:39
|
NOAA Determines TMC USA′s Consolidated Deep-Seabed Mining Application is in Substantial Compliance (GlobeNewswire EN)
|
|
|
NEW YORK, March 09, 2026 (GLOBE NEWSWIRE) -- TMC the metals company Inc. (Nasdaq: TMC) (“TMC” or the “Company”), a leading developer of the world's largest resource of critical metals essential to energy, defense, manufacturing and infrastructure, today announced that the National Oceanic and Atmospheric Administration (NOAA) has determined that the consolidated application submitted by the Company's subsidiary, The Metals Company USA LLC (“TMC USA”), for an exploration license and commercial recovery permit under the Deep Seabed Hard Mineral Resources Act (DSHMRA) is in substantial compliance with the requirements of the Act and its implementing regulations....
|
|
|
09.03.26 - 13:39
|
IP Strategy to Participate at the Canaccord Genuity 6th Annual Digital Assets Virtual Symposium (GlobeNewswire EN)
|
|
|
GIG HARBOR, Wash., March 09, 2026 (GLOBE NEWSWIRE) -- IP Strategy Holdings, Inc. (Nasdaq: IPST) (the “Company” or “IP Strategy”), the first company to adopt a treasury reserve policy centered on the $IP token, today announced that Justin Stiefel, Chief Executive Officer, and Phil Blows, Chief Investment Officer, will participate in a fireside chat at the Canaccord Genuity 6th Annual Digital Assets Virtual Symposium on Wednesday, March 11, 2026 at 12:00 PM Pacific Time / 3:00 PM Eastern Time. The Company will also host individual and small group investor meetings throughout the day....
|
|
|
09.03.26 - 13:33
|
Jet.AI Inc. Reports Full Year 2025 Financial Results (GlobeNewswire EN)
|
|
|
LAS VEGAS, March 09, 2026 (GLOBE NEWSWIRE) -- Jet.AI Inc. (“Jet.AI” or the “Company”) (Nasdaq: JTAI), an emerging provider of high-performance GPU infrastructure and AI cloud services, today announced financial results for the full year ended December 31, 2025. The Company had approximately $13.7 million of cash and no debt as of March 5th, 2026 (vs $1.8 million at year end 2025) and is Net Income positive for the full year 2025 ($4.6 million in 2025 vs -$12.7 million in 2024). In the first quarter of 2026, Jet.AI expects the completion of the third milestone of its Canadian data center joint venture - related to powered land at its 385 acre Manitoba site and continued progress in the Maritimes. The power study for our Moapa NV data center site is ongoing, and the flyExclusive transaction remains on track to close April 30th. The Company maintains strong access to capital through its $250 million shelf facility...
|
|
|
09.03.26 - 13:33
|
UPDATE – Visionary Doubles Down on High-Margin Medical Aesthetics with US$12 Million Exclusive Agreement, Initiates Strategic Exit from Non-Core Businesses (GlobeNewswire EN)
|
|
|
HONG KONG, March 09, 2026 (GLOBE NEWSWIRE) -- Visionary Holdings Inc. (NASDAQ: GV) (“the Company”), a technology-driven multinational enterprise focused on biotechnology and healthcare, today announced that its wholly owned subsidiary, Visionary Health Technology Group Limited (“GV Hong Kong”), has signed a US$12 million exclusive distribution agreement for its flagship anti-aging product, Premier Regenerative Complex-President Super Injection, in cooperation with Huajin China Investment Company(”Huajin China”), alongside the Board-approved divestiture of its non-core business....
|
|
|
|
|
09.03.26 - 13:33
|
Hudson Technologies to Attend 38th Annual Roth Conference (GlobeNewswire EN)
|
|
|
WOODCLIFF LAKE, N.J., March 09, 2026 (GLOBE NEWSWIRE) -- Hudson Technologies, Inc. (NASDAQ: HDSN) a leading provider of innovative and sustainable refrigerant products and services to the Heating, Ventilation, Air Conditioning, and Refrigeration industry – and one of the nation's largest refrigerant reclaimers – today announced that Ken Gaglione, President and Chief Executive Officer and Brian Bertaux, Chief Financial Officer will attend the 38th Annual Roth Conference on Monday, March 23, 2026 at The Ritz-Carlton, Laguna Niguel in Dana Point, California. Messrs. Gaglione and Bertaux will be available for one-on-one meetings throughout the day....
|
|
|
09.03.26 - 13:33
|
Alico to Participate at 38th Annual Roth Conference (GlobeNewswire EN)
|
|
|
FORT MYERS, Fla., March 09, 2026 (GLOBE NEWSWIRE) -- Alico, Inc. (“Alico” or the “Company”) (Nasdaq: ALCO) today announced that John Kiernan, the Company's President and Chief Executive Officer, will host one-on-one meetings with investors at the 38th Annual Roth Conference, taking place in Laguna Niguel, CA on March 22-24, 2026....
|
|
|
|
|
09.03.26 - 13:33
|
Profound Medical to Host Investor Call to Discuss First Clinical Outcomes from the CAPTAIN Trial on March 13; Participate in ROTH Investor Conference on March 22-24 (GlobeNewswire EN)
|
|
|
TORONTO, March 09, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue, today announced that the first clinical outcomes from the Level 1 post-market CAPTAIN trial comparing the safety and efficacy of the TULSA Procedure™ with robotic radical prostatectomy in men with localized prostate cancer are scheduled to be presented during the Late-Breaking and High-Impact session at the 41st Annual European Association of Urology (“EAU 2026”) Congress in London, UK on March 13, 2026 at 9:40 a.m. EDT (1:40 p.m. GMT)....
|
|
|
|
|
|
|
09.03.26 - 13:33
|
Prairie Operating Co. Announces Participation in Upcoming Conference (GlobeNewswire EN)
|
|
|
HOUSTON, TX, March 09, 2026 (GLOBE NEWSWIRE) -- Prairie Operating Co. (Nasdaq: PROP) (the “Company” or “Prairie”), an independent energy company engaged in the development and acquisition of oil and natural gas resources in the Denver-Julesburg (DJ) Basin – today announced that members of its senior management team will participate in the upcoming investor conference....
|
|